Cargando…
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
Autores principales: | Wilson, John, Cullup, Hannah, Lourie, Rohan, Sheng, Yonghua, Palkova, Anna, Radford, Kristen J., Dickinson, Anne M., Rice, Alison M., Hart, Derek N.J., Munster, David J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715036/ http://dx.doi.org/10.1084/jem.20070723041509c |
Ejemplares similares
-
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
por: Wilson, John, et al.
Publicado: (2009) -
Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
por: Li, Ziduo, et al.
Publicado: (2020) -
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
por: Li, Ziduo, et al.
Publicado: (2019) -
Human CD141(+) (BDCA-3)(+) dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
por: Jongbloed, Sarah L., et al.
Publicado: (2010) -
Targeting CD83 for the treatment of graft-versus-host disease
por: WANG, XIONGFEI, et al.
Publicado: (2013)